[PHARMA] QoQ TTM Result on 30-Sep-2019 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-Nov-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Sep-2019 [#3]
Profit Trend
QoQ- -30.11%
YoY- -43.39%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 2,898,216 2,854,343 2,820,530 2,701,491 2,572,302 2,553,141 2,384,956 13.88%
PBT -189,383 -191,228 -191,865 58,549 72,267 71,756 70,220 -
Tax 43,048 44,548 42,418 -24,693 -23,482 -26,467 -26,990 -
NP -146,335 -146,680 -149,447 33,856 48,785 45,289 43,230 -
-
NP to SH -145,739 -146,437 -149,219 33,816 48,386 44,499 42,468 -
-
Tax Rate - - - 42.17% 32.49% 36.88% 38.44% -
Total Cost 3,044,551 3,001,023 2,969,977 2,667,635 2,523,517 2,507,852 2,341,726 19.14%
-
Net Worth 357,891 350,047 336,573 516,387 518,564 528,825 509,862 -21.03%
Dividend
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Div 22,204 22,188 22,144 27,347 40,348 44,226 41,587 -34.21%
Div Payout % 0.00% 0.00% 0.00% 80.87% 83.39% 99.39% 97.93% -
Equity
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Net Worth 357,891 350,047 336,573 516,387 518,564 528,825 509,862 -21.03%
NOSH 261,705 261,229 261,229 261,229 261,229 260,505 260,505 0.30%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -5.05% -5.14% -5.30% 1.25% 1.90% 1.77% 1.81% -
ROE -40.72% -41.83% -44.33% 6.55% 9.33% 8.41% 8.33% -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 1,109.43 1,092.66 1,081.04 1,035.84 987.13 980.07 916.82 13.56%
EPS -55.79 -56.06 -57.19 12.97 18.57 17.08 16.33 -
DPS 8.50 8.50 8.50 10.50 15.50 17.00 16.00 -34.43%
NAPS 1.37 1.34 1.29 1.98 1.99 2.03 1.96 -21.25%
Adjusted Per Share Value based on latest NOSH - 261,229
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 201.09 198.05 195.70 187.44 178.48 177.15 165.48 13.88%
EPS -10.11 -10.16 -10.35 2.35 3.36 3.09 2.95 -
DPS 1.54 1.54 1.54 1.90 2.80 3.07 2.89 -34.29%
NAPS 0.2483 0.2429 0.2335 0.3583 0.3598 0.3669 0.3538 -21.04%
Price Multiplier on Financial Quarter End Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 -
Price 2.22 1.26 2.06 2.44 2.84 2.27 2.78 -
P/RPS 0.20 0.12 0.19 0.24 0.29 0.23 0.30 -23.70%
P/EPS -3.98 -2.25 -3.60 18.82 15.29 13.29 17.03 -
EY -25.13 -44.49 -27.76 5.31 6.54 7.53 5.87 -
DY 3.83 6.75 4.13 4.30 5.46 7.49 5.76 -23.83%
P/NAPS 1.62 0.94 1.60 1.23 1.43 1.12 1.42 9.19%
Price Multiplier on Announcement Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 19/08/20 19/05/20 20/02/20 20/11/19 23/08/19 16/05/19 21/02/19 -
Price 4.42 1.88 2.04 2.21 2.66 2.36 2.76 -
P/RPS 0.40 0.17 0.19 0.21 0.27 0.24 0.30 21.16%
P/EPS -7.92 -3.35 -3.57 17.04 14.33 13.82 16.91 -
EY -12.62 -29.82 -28.04 5.87 6.98 7.24 5.92 -
DY 1.92 4.52 4.17 4.75 5.83 7.20 5.80 -52.17%
P/NAPS 3.23 1.40 1.58 1.12 1.34 1.16 1.41 73.86%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment